# NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents

> **NCT02763475** · PHASE2 · COMPLETED · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 7 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Leukemia
- Myeloid Leukemia

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** Fludarabine
- **PROCEDURE:** NK cell infusion
- **DRUG:** IL-2

## Key facts

- **NCT ID:** NCT02763475
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02763475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02763475, "NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02763475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*